rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lynne Marie Sullivan

Director

Company insider

Files Form 4 as: Director, Solid Biosciences; Director, Inozyme Pharma; CFO & Head of Corp. Dev., Unity Biotechnology; Director, BiomX; Director, Adicet Bio.

Every Form 4 they filed

In numbers

Trades disclosed
49
Buys
1
Sells
5
Bought
$50K
Sold
$24K
Companies
5
Companies where not an officer
4
First trade
25 Jul 2018
Last trade
10 Jun 2026
Last filed
11 Jun 2026

Companies traded

Where they are an officer
Unity BiotechnologyOfficer · last 2 Apr 20250 buys · 5 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SLDB Solid BiosciencesDirector · Biotechnology · last 10 Jun 20260 buys · 0 sells
Inozyme PharmaDirector · last 1 Jul 20250 buys · 0 sells
BiomXDirector · Biotechnology · last 1 Mar 20231 buy · 0 sells
ACET Adicet BioDirector · Biotechnology · last 3 Jun 20200 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 11 Jun 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
10 Jun 2026filed 11 Jun 2026SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
1 Jul 2025filed 3 Jul 2025Inozyme Pharmaoption or derivativeSEC FORM 4 Code D—28,368filing
12 Jun 2025filed 13 Jun 2025SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—77,500 at $0.00filing
2 Apr 2025filed 3 Apr 2025Unity BiotechnologySEC FORM 4 Sold$23K21,867 at $1.03filing
28 Mar 2025filed 31 Mar 2025Unity Biotechnologyoption or derivativeSEC FORM 4 Code A—106,000 at $0.00filing
28 Mar 2025filed 31 Mar 2025Unity BiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
4 Feb 2025filed 5 Feb 2025Unity BiotechnologySEC FORM 4 Sold$341153 at $2.23filing
22 Jan 2025filed 23 Jan 2025Unity Biotechnologyoption or derivativeSEC FORM 4 Code A—150,000 at $0.00filing
4 Nov 2024filed 6 Nov 2024Unity BiotechnologySEC FORM 4 Sold$175136 at $1.29filing
2 Aug 2024filed 6 Aug 2024Unity BiotechnologySEC FORM 4 Sold$213139 at $1.53filing
25 Jun 2024filed 26 Jun 2024Unity BiotechnologySEC FORM 4 Sold$454324 at $1.40filing
18 Jun 2024filed 20 Jun 2024Inozyme Pharmaoption or derivativeSEC FORM 4 Code A—28,000 at $0.00filing
11 Jun 2024filed 13 Jun 2024SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—34,400 at $0.00filing
13 Jun 2023filed 15 Jun 2023Inozyme Pharmaoption or derivativeSEC FORM 4 Code A—16,000 at $0.00filing
6 Jun 2023filed 8 Jun 2023SLDB Solid Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—9,650 at $0.00filing
11 May 2023filed 12 May 2023Unity Biotechnologyoption or derivativeSEC FORM 4 Code A$111K40,000 at $2.77filing
11 May 2023filed 12 May 2023Unity Biotechnologyoption or derivativeSEC FORM 4 Code D—24,000 at $0.00filing
11 May 2023filed 12 May 2023Unity Biotechnologyoption or derivativeSEC FORM 4 Code A—24,000 at $0.00filing
11 May 2023filed 12 May 2023Unity Biotechnologyoption or derivativeSEC FORM 4 Code D—12,333 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.